Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Heterozygous variants in the CD36 gene linked to bleeding phenotypes

Feb. 8, 2022

A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress

Feb. 3, 2022

HMGB1 restricts EPO signaling, contributing to anemia of inflammation

Feb. 2, 2022

MAP3K7 modulation to treat MDS-associated anemia

Jan. 10, 2022

Hematologic

Jan. 1, 2022

Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia

Dec. 29, 2021

Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders

Dec. 17, 2021

Generation Bio reports progress in hemophilia A program

Dec. 15, 2021

ASP-8731 inhibits microvascular stasis in models of sickle cell disease

Dec. 15, 2021

CRISPRa-mediated SEC23A activation rescues SEC23B-deficient CDAII in vivo

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.